REP Receives Federal Cannabis Research Licenses
The Drug Enforcement Administration (DEA) issued three permits in December to Royal Emerald Pharmaceuticals (REP) for cultivation, research, development, and …
January 25, 2022/
Business, Cannabis, Industry, marijuana, medical cannabis, regulation, Research, Science and medicine, study/